NCT00789282

Brief Summary

The purpose of the study is to determine the efficacy of a family physician practice-based model of chronic disease management (CDM) based in Primary Care Networks (PCN's) that is integrated with the Capital Health Regional Diabetes Program for care of patients with type 2 Diabetes Mellitus.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Feb 2008

Longer than P75 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2008

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 12, 2008

Completed
6 months until next milestone

First Posted

Study publicly available on registry

November 11, 2008

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2011

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

May 19, 2017

Status Verified

April 1, 2016

Enrollment Period

3 years

First QC Date

May 12, 2008

Last Update Submit

May 17, 2017

Conditions

Keywords

chronic diseaseFamily Physicianprimary care networkpractice-based modeltype 2 diabetescomplicationssequelae

Outcome Measures

Primary Outcomes (1)

  • A higher proportion of patients with type 2 diabetes enrolled in the 'enhanced care' arm compared with the patients enrolled 'usual' care' arm will achieve an absolute reduction in their HbaA1c of 1.0% or greater during the study period.

    1 year

Secondary Outcomes (1)

  • A higher proportion of patients with type 2 diabetes in the 'enhanced care' arm compared with the patients enrolled in 'usual care' arm will achieve a 10% or greater reduction in HbA1c values during the study period.

    1 year

Study Arms (2)

Usual Care Group

ACTIVE COMPARATOR

The 'usual care' study arm (control) will reflect current patterns of care for patients with thpe 2 diabetes in the Capital Health region

Other: reflects current patterns of care

Enhanced Care Group

EXPERIMENTAL

In the enhanced care group(intervention arm) the participants will receive a multifactorial intervention with three main components that include: optimized medical management, 2) support for development of enhanced patient self management skills, and 3) organized proactive follow-up by chronic disease management teams to support improvement in care.

Other: multidisciplinary approachOther: multifactorial approach - for enhanced care group

Interventions

Provides an integrated, proactive approach to the management of patients with chronic diseases (ie: diabetes and sequelae) Wagner Model- care encompassed in 3 overlapping galaxies: wider community; the health care system; and the provider organization. There are 6 essential elements: community resources and policies; health care organization; patient self-management support; delivery system design; decision support; and clinical information systems.

Enhanced Care Group

optimized medical management support for development of enhanced patient self management skills organized proactive follow-up chronic disease management teams

Enhanced Care Group

Continue under the care of their family physician and specialists with referral to diabetic assessment and treatment centers at the discretion of the patient and physician. Normal manner of care: could attend diabetic self education classes and consultations regarding management of diabetes. Or, participate in other patient self management program of their choice.

Usual Care Group

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with type 2 diabetes (2003 classification by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus) receiving any therapy with HbA1c of \> or = 7.0% between the ages of 40 - 75 years.

You may not qualify if:

  • Type 1 diabetes
  • Pregnancy
  • Severe diabetic complications that include end stage renal disease requiring dialysis
  • Proliferative retinopathy (growth of new vessels on the retina and posterior surface of the vitreous that requires laser therapy)
  • Uncontrolled cardiovascular disease (CVS event within 1 year of enrollment)
  • Psychiatric disease or cognitive impairment that would interfere with treatment compliance
  • Cancer or terminally ill patients with less than 6 months life expectancy
  • Blindness
  • Other severe co- morbid diseases
  • Participation in another intense multifactorial intervention for the management of type 2 diabetes
  • Participation in another study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta, Dept of Family Medicicne

Edmonton, Alberta, T6G - 2C8, Canada

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Chronic Disease

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Neil Bell, MD,MSc,CCFP,FCFP

    Professor, Dept of Family Medicine, University of Alberta

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 12, 2008

First Posted

November 11, 2008

Study Start

February 1, 2008

Primary Completion

February 1, 2011

Study Completion

December 1, 2011

Last Updated

May 19, 2017

Record last verified: 2016-04

Locations